Key Highlights

  • Second-quarter RBR was $465.6 million, up 15.7%, with organic growth of 10.8%.
  • Diluted EPS was $1.91, up 75.2%.
  • 2026 adjusted diluted EPS guidance was raised to $9.00–$9.40.
  • Year-to-date repurchases totalled $208.6 million.

Huron Consulting Group Inc. (NASDAQ:HURN) provides consulting services to healthcare, education and commercial clients. In late July it reported record second-quarter revenue, raised its 2026 outlook and disclosed more than $200 million of year-to-date share repurchases. Those developments may matter to those following professional services companies, where demand, utilization and capital returns are closely watched.

Latest Company Context

Second-quarter 2026 revenue before reimbursable expenses (RBR) was $465.6 million, up 15.7%; organic growth was 10.8%, excluding $19.5 million from acquisitions. Net income was $31.2 million, up 60.8%, with diluted EPS of $1.91, up 75.2%. Adjusted EBITDA rose 19.9% to $72.6 million (15.6% of RBR), adjusted diluted EPS was $2.46, up 30.2%, and operating cash flow was $120.5 million.

Management raised 2026 guidance to RBR of $1.85 billion to $1.89 billion (from $1.78 billion to $1.86 billion), adjusted EBITDA margin of 14.5% to 15.0% (unchanged), and adjusted diluted EPS of $9.00 to $9.40 (from $8.35 to $9.15). These are company expectations. Year to date, Huron repurchased $208.6 million of shares, including $155.5 million in the first quarter. On June 3, it agreed to acquire RelateCare, an AI-enabled clinical and patient access provider, with terms undisclosed.

Key Business Drivers

Healthcare and education demand drives much of the business, with clients pursuing operational, financial and technology transformation. Organic growth of 10.8% in the quarter suggests demand held up, while acquisitions added further revenue.

Margins and capital allocation are the other drivers. The guided adjusted EBITDA margin of 14.5% to 15.0% implies profit growth is expected to come mostly from higher volume, and the company's buybacks may lift per-share results if sustained.

Risks include client budget pressure, healthcare policy changes and talent costs.

What Investors Should Watch

Investors may watch the third-quarter 2026 results, likely around late October, for whether guidance is maintained or raised again. Completion and contribution of RelateCare, further buybacks, and utilization and bill rates may be informative. Healthcare sector spending trends and federal policy could also influence demand.

Record Revenue, a Raised Outlook and Heavy Repurchases

Huron paired record second-quarter revenue and a raised outlook with heavy share repurchases and a pending RelateCare acquisition. Whether guidance is raised again at the next report is the near-term marker.